Kairos Pharma, LTD. SEC filings KAPA
Kairos Pharma, LTD. has 125 filings in SEC EDGAR's recent list, going back to Mar 29, 2023. Its latest annual report, Form ARS, was filed on May 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 3, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Other events
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 21, 2026 | Aug 21, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 22, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Other events
|
Jul 15, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 30, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Other events
|
Jun 4, 2026 | Jun 4, 2026 |
| DEFA14A | Additional proxy material | May 26, 2026 | — |
| ARS | Annual report to shareholders | May 22, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | May 22, 2026 | May 22, 2026 |
| 8-K |
Current report
Other events
|
May 18, 2026 | May 18, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| PRE 14A | Preliminary proxy statement | May 11, 2026 | May 11, 2026 |
| 424B3 | Prospectus | Apr 1, 2026 | — |
| 424B3 | Prospectus | Apr 1, 2026 | — |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Other events
|
Feb 26, 2026 | Feb 26, 2026 |
| EFFECT | Filing | Jan 23, 2026 | — |
| CORRESP | Letter to the SEC | Jan 21, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 15, 2026 | — |
| S-3 | Shelf registration | Jan 13, 2026 | — |
| 4 | Insider transaction | Dec 30, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Sep 16, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Sep 16, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Oct 8, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 7, 2025 | Oct 1, 2025 |
| 8-K |
Current report
Other events
|
Sep 18, 2025 | Sep 18, 2025 |
| 8-K |
Current report
Other events
|
Sep 11, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Other events
|
Sep 3, 2025 | Sep 3, 2025 |
| 424B3 | Prospectus | Aug 19, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 10-K/A | Amended annual report | Jul 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Jul 15, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Jun 12, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Other events
|
Jun 3, 2025 | Jun 3, 2025 |
| DEFR14A | Filing | May 16, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| PRER14A | Filing | May 6, 2025 | — |
| DEF 14A | Proxy statement | May 1, 2025 | Apr 30, 2025 |
| 3 | Initial insider ownership | Apr 30, 2025 | Dec 10, 2024 |
| 10-K/A | Amended annual report | Apr 29, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Auditor change
|
Apr 28, 2025 | Apr 23, 2025 |
| 424B3 | Prospectus | Apr 25, 2025 | — |
| EFFECT | Filing | Apr 24, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 24, 2025 | Apr 24, 2025 |
| CORRESP | Letter to the SEC | Apr 22, 2025 | — |
| S-1 | Registration statement | Apr 22, 2025 | — |
| 10-K | Annual report | Apr 15, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Apr 7, 2025 | Jan 1, 2025 |
| NT 10-K | Filing | Mar 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Mar 20, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Other events
|
Feb 26, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 24, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Feb 24, 2025 | Jan 1, 2025 |
| DEF 14C | Information statement | Feb 10, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Other events
|
Feb 6, 2025 | Feb 6, 2025 |
| 424B3 | Prospectus | Feb 5, 2025 | — |
| EFFECT | Filing | Feb 4, 2025 | — |
| CORRESP | Letter to the SEC | Jan 31, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2025 | — |
| PRE 14C | Filing | Jan 29, 2025 | Jan 29, 2025 |
| S-1 | Registration statement | Jan 29, 2025 | — |
| D | Filing | Jan 28, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 17, 2025 | Jan 16, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 14, 2025 | Jan 14, 2025 |
| UPLOAD | Letter from the SEC | Jan 6, 2025 | — |
| DRS | Filing | Jan 3, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Dec 13, 2024 | Dec 10, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 25, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 21, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 19, 2024 | Nov 19, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Oct 10, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 4, 2024 | Oct 1, 2024 |
| S-8 | Employee stock plan registration | Sep 27, 2024 | — |
| 8-K |
Current report
Material agreement
|
Sep 27, 2024 | Sep 23, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 24, 2024 | Sep 20, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 17, 2024 | Sep 16, 2024 |
| 424B4 | Prospectus | Sep 17, 2024 | — |
| EFFECT | Filing | Sep 16, 2024 | — |
| CORRESP | Letter to the SEC | Sep 13, 2024 | — |
| CORRESP | Letter to the SEC | Sep 13, 2024 | — |
| CORRESP | Letter to the SEC | Sep 13, 2024 | — |
| CERT | Nyse american certification | Sep 12, 2024 | — |
| 8-A12B | Filing | Sep 12, 2024 | — |
| CORRESP | Letter to the SEC | Sep 9, 2024 | — |
| CORRESP | Letter to the SEC | Sep 9, 2024 | — |
| S-1/A | Amended registration statement | Aug 16, 2024 | — |
| S-1/A | Amended registration statement | Jun 4, 2024 | — |
| CORRESP | Letter to the SEC | Jun 3, 2024 | — |
| S-1/A | Amended registration statement | May 24, 2024 | — |
| S-1/A | Amended registration statement | May 20, 2024 | — |
| S-1/A | Amended registration statement | May 13, 2024 | — |
| S-1/A | Amended registration statement | May 1, 2024 | — |
| S-1/A | Amended registration statement | Feb 14, 2024 | — |
| S-1/A | Amended registration statement | Dec 7, 2023 | — |
| S-1 | Registration statement | Sep 29, 2023 | — |
| DRS/A | Filing | Sep 18, 2023 | — |
| DRSLTR | Filing | Sep 15, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2023 | — |
| DRSLTR | Filing | Jun 28, 2023 | — |
| DRS/A | Filing | Jun 28, 2023 | — |
| DRS/A | Filing | Jun 28, 2023 | — |
| D | Filing | Apr 27, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2023 | — |
| DRS | Filing | Mar 29, 2023 | — |
Showing 125 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KAPA (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1962011
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.